Header Logo

Connection

Lorin Olson to Humans

This is a "connection" page, showing publications Lorin Olson has written about Humans.
Connection Strength

0.110
  1. Involvement of PDGF in fibrosis and scleroderma: recent insights from animal models and potential therapeutic opportunities. Curr Rheumatol Rep. 2013 Feb; 15(2):304.
    View in: PubMed
    Score: 0.024
  2. Homeodomain-mediated beta-catenin-dependent switching events dictate cell-lineage determination. Cell. 2006 May 05; 125(3):593-605.
    View in: PubMed
    Score: 0.015
  3. PROX1 Inhibits PDGF-B Expression to Prevent Myxomatous Degeneration of Heart Valves. Circ Res. 2023 09; 133(6):463-480.
    View in: PubMed
    Score: 0.013
  4. Paired-like repression/activation in pituitary development. Recent Prog Horm Res. 2003; 58:249-61.
    View in: PubMed
    Score: 0.012
  5. Perspective: genetic and genomic approaches in elucidating mechanisms of pituitary development. Endocrinology. 2002 Jun; 143(6):2007-11.
    View in: PubMed
    Score: 0.012
  6. Dysregulated mesenchymal PDGFR-ß drives kidney fibrosis. EMBO Mol Med. 2020 03 06; 12(3):e11021.
    View in: PubMed
    Score: 0.010
  7. Complementary Wnt Sources Regulate Lymphatic Vascular Development via PROX1-Dependent Wnt/ß-Catenin Signaling. Cell Rep. 2018 10 16; 25(3):571-584.e5.
    View in: PubMed
    Score: 0.009
  8. Pigment epithelium-derived factor, a noninhibitory serine protease inhibitor, is renoprotective by inhibiting the Wnt pathway. Kidney Int. 2017 03; 91(3):642-657.
    View in: PubMed
    Score: 0.008
  9. Detrimental effects of duplicate reads and low complexity regions on RNA- and ChIP-seq data. BMC Bioinformatics. 2015; 16 Suppl 13:S10.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.